This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Share
Stay up to date

Home
Topics
Webinars/Videos
Infographics
Articles
Case Studies
Forum
Faculty
Unblocked
Webinar
Stay up to date

Articles

Lipoprotein(a): cardiovascular risk and emerging therapies

Fujino M, Nicholls SJ

Journal:

Expert Rev Cardiovasc Ther

First published: April 3, 2023 DOI: 10.1080/14779072.2023.2197593

Abstract

You might also like...

Running time: 3 minutes, 26 seconds
Webinars/Videos
The SANTORINI Study: Why Are Lipid Control Therapies Not Working?
In this video, we summarize the results from the SANTORINI trial which documents the effectiveness of current treatment practice in managing LDL-C levels for patients in the higher CV risk categories in and how care may be improved.
Fujino M, Nicholls SJ
Journal:
Expert Rev Cardiovasc Ther

First published: April 3, 2023 DOI: 10.1080/14779072.2023.2197593
View
- Share
Infographics
Therapeutic Management of Dyslipidaemia: New Strategies
Novel pharmacological interventions targeting lipids can lower the incidence of dyslipidaemia triggered cardiovascular events. Check out and download our latest infographic providing insights into evolution of lipid-lowering therapeutics and status of novel therapeutics highlighting their development, safety, and efficacy.
Fujino M, Nicholls SJ
Journal:
Expert Rev Cardiovasc Ther

First published: April 3, 2023 DOI: 10.1080/14779072.2023.2197593
View
- Share
Case Studies
Quiz of the month – May 2023
Take this short quiz to test your knowledge on some of the latest peer-reviewed published literature related to ASCVD and Lipidology.
Fujino M, Nicholls SJ
Journal:
Expert Rev Cardiovasc Ther

First published: April 3, 2023 DOI: 10.1080/14779072.2023.2197593
Take
- Share

How would you rate this content?

© John Wiley & Sons, Ltd. All rights reserved.
Privacy Policy
Terms of use
Stay up to date
Cookie Preferences
This Knowledge Hub is supported by Novartis.